Takeda Pharmaceutical Co Ltd Growth & Emerging Markets Strategic Update Call Transcript
' -
Hello, everyone, and thank you for joining Takeda's investor call focusing on our growth and emerging markets business unit. My name is Christopher O'Reilly, Global Head of Investor Relations.
Before we start, I'd like to remind everyone that we will be discussing forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those discussed today. The factors that could cause our actual results to differ materially are discussed in our most recent Form 20-F and in our other SEC filings. Please also refer to the important notice on Page 2 of today's presentation.
Turning to Slide 3. I would like to introduce our main speakers today: Ricardo Marek, President of Takeda's Growth and Emerging Markets business unit, and Costa Saroukos, Chief Financial Officer.
Moving next to the agenda on Slide 4. First, Costa will give a brief introduction to today's event. Following that,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
